ATP is degraded via CD39 into AMP that is further degraded into adenosine by the ecto-5′-nucleotidase enzyme of CD73, this pathway could affect the immune response against cancers [8,9,10,11,12]. The gene discussed is ENTPD1; the disease is cancer.